Born in the early nineteen nineties, evidence-based medicine (EBM) is a paradigm intended to promote the integration of biomedical evidence into the physicians daily practice. This paradigm requires the continuous study of diseases to provide the best scientific knowledge for supporting physicians in their diagnosis and treatments in a close way. Within this paradigm, usually, health experts create and publish clinical guidelines, which provide holistic guidance for the care for a certain disease. The creation of these clinical guidelines requires hard iterative processes in which each iteration supposes scientific progress in the knowledge of the disease. To perform this guidance through telehealth, the use of formal clinical guidelines will allow the building of care processes that can be interpreted and executed directly by computers. In addition, the formalization of clinical guidelines allows for the possibility to build automatic methods, using pattern recognition techniques, to estimate the proper models, as well as the mathematical models for optimizing the iterative cycle for the continuous improvement of the guidelines. However, to ensure the efficiency of the system, it is necessary to build a probabilistic model of the problem. In this paper, an interactive pattern recognition approach to support professionals in evidence-based medicine is formalized.
Samsung ha ofrecido hoy una conferencia sobre tecnologías de la salud en la que ha presentado su idea en materia de wearables para cuantificar nuestra salud en el futuro. La compañía ha presentado Simband, un ecosistema de sensores de código abierto pensados para construir una plataforma universal desde la que vigilar nuestras constantes vitales.
Last week, the World Health Organization recommended unequivocally that all HIV-negative men who have sex with men take HIV-preventing drugs like Truvada. The new guidelines build on a similar proposal from the CDC, but they go a step further, suggesting that even gay men who regularly use condoms should take these drugs as a backup measure. If doctors...
Despite the potential of telehealth services to increase the quality and accessibility of healthcare, the success rate of such services has been disappointing. The purpose of this paper is to find and compare existing frameworks for the implementation of telehealth services that can contribute to the success rate of future endeavors. After a thorough discussion of these frameworks, this paper outlines the development methodologies in terms of theoretical background, methodology and validation. Finally, the common themes and formats are identified for consideration in future implementation. It was confirmed that a holistic implementation approach is needed, which includes technology, organizational structures, change management, economic feasibility, societal impacts, perceptions, user-friendliness, evaluation and evidence, legislation, policy and governance. Furthermore, there is some scope for scientifically rigorous framework development and validation approaches.
Nuevos estudios alertan que la sal ya puede considerarse como una droga, no sólo por los efectos perjudiciales que provoca en nuestra salud, sino también por la alta capacidad adictiva que posee. Alta adicción Un estudio elaborado en ratones por las universidades de Duke y Melbourne demostró que la necesidad de consumir sal era la misma que la relacionada con la adicción a la cocaína o a los opiáceos como la heroína.
Las redes sociales aplicadas a la salud, la salud 2.0, permiten a los profesiones sanitarios transmitir su experiencia a un rango amplio de personas, conocer mejor las necesidades de sus pacientes, actualizar sus conocimientos y acceder a colegas o autoridades relevantes en sus respectivos campos, entre otras ventajas. Sin embargo, a menudo surgen dudas sobre los límites entre lo que se puede comunicar y lo que no. Por ese motivo, desde la agencia COM Salud hemos un decálogo de recomendaciones en el manejo de redes sociales para el profesional de la salud basado en las guías del General Medical Council del Reino Unido y del Colegio de Médicos de Barcelona.
The Chairman and CEO of DNA Electronics, a provider of point-of-care genomic diagnostics solutions for medical and healthcare applications, Chris Toumazou, has been awarded the European Inventor Award 2014 in the Research category, for his rapid USB-based DNA testing device.
Announced at the European Inventor Awards ceremony in Berlin on June 17th 2014, Toumazou’s win recognises his contribution to medical research with his ground-breaking invention. The device, which can show the results of a DNA test within minutes, uses silicon transistors to identify DNA and RNA, offering a simpler, cheaper and more discrete alternative to existing DNA analysis equipment.
The invention involves the amplification and detection of DNA and other biomolecules using pH measurement, providing the ground work for DNA Electronics’ molecular diagnostics platform Genalysis®. With the capability of identifying genomic sequences, not only in patients, but also in infectious agents, the company is developing products that will provide clinicians with rapid actionable diagnosis of life-threatening conditions.
DNA Electronicsis a developer of semiconductor solutions for real-time nucleic acid detection which enables faster, simpler and more cost-effective DNA analysis platforms.
A spin-out of Imperial College London, DNA Electronics was founded by Professor Toumazou following his invention of the company’s core technology that allows CMOS transistors to be switched on and off with DNA – the key invention enabling semiconductor-based sequencing. Prof. Toumazou’s innovation has culminated in the world’s first DNA logic on standard CMOS technology.
The company’s IP portfolio includes techniques for monitoring nucleotide insertions using ion-sensitive transistors, enabling label-free electronic DNA sequencing and diagnostics platforms. DNA Electronics (DNAe) has developed the ground-breaking Genalysis® platform of disposable silicon chip-based solutions for real-time nucleic acid sequence detection at the point of care, providing end users with technology as yet unavailable outside a laboratory.
DNA Electronics has a non-exclusive, field-limited licensing agreement with Ion Torrent (now part of Thermo Fisher Scientific), whose next generation sequencing technology is based on DNA Electronics’ semiconductor sequencing IP. DNA Electronics has also licensed its Genalysis® technology platform to GENEU™, a company that is delivering on-the-spot genetic analytics services for cosmetics and skincare applications.
“Harvard demuestra que pesticidas de Bayer están matando abejas Harvard demuestra que pesticidas de Bayer están matando abejas www.ecoportal.net Dos pesticidas neocotinoides prohibidos ya en Europa están matando a las abejas de Estados Unidos en el...”
Your smartphone is not only your best friend, it's also become your personal trainer, coach, medical lab and maybe even your doctor.
"Digital health" has become a key focus for the technology industry, from modest startups' focus on apps to the biggest companies in the sector seeking to find ways to address key issues of health and wellness.
Apps that measure heart rate, blood pressure, glucose and other bodily functions are multiplying, while Google, Apple and Samsung have launched platforms that make it easier to integrate medical and health services.
"We've gotten to a point where with sensors either in the phone or wearables gather information that we couldn't do in the past without going to a medical center," says Gerry Purdy, analyst at Compass Intelligence.
"You can do the heart rate, mobile EKGs (electrocardiograms). Costs are coming down, and these sensors are becoming more socially acceptable."
The consultancy Rock Health estimates 143 digital health companies raised $2.3 billion in the first six months of 2014, already topping last year's amount.
Recent studies suggest that people who use connected devices to monitor health and fitness often do a better job of managing and preventing health problems.
A study led by the Center for Connected Health found that people who use mobile devices did a better job of lowering dangerous blood pressure and blood sugar levels.
A separate study published in the July 2014 issue of Health Affairs found that data collected by devices is not only useful for patients but can help doctors find better treatments.
"When linked to the rest of the available electronic data, patient-generated health data completes the big data picture of real people's needs, life beyond the health care system," said Amy Abernethy, a Duke University professor of medicine lead author of the study.
Some firms have even more ambitious plans for health technology.
Google, for example, is developing a connecting contract lens which can help monitor diabetics and has set up a new company called Calico to focus on health and well-being, hinting at cooperation with rivals such as Apple. And IBM is using its Watson supercomputer for medical purposes including finding the right cancer treatment.